Detail
| LncRNA Name | PVT1 |
| Synonyms | PVT1, LINC00079, MYC, NCRNA00079, onco-lncRNA-100, MIR1204HG |
| Region | GRCh38_8:127794533-128101253 Sequence |
| Ensembl | ENSG00000249859 |
| RefSeq | NR_003367 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✔ |
| Variant | ✔ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, Cell proliferation assay, Flow cytometric assay, Luciferase reporter assay, etc. |
| Sample | Three human OC cell lines (HEY, SKOV-3, OVCAR-3), normal human ovary cell line (IOSE80). OC tissues. |
| Expression Pattern | up-regulated |
| Function Description | Taken together, our finding shows that PVT1 may be a novel biomarker for prognosis and a promising therapeutic target for OC.Patients were divided into high PVT1 expression group and low PVT1 expression group on the basis of the median of PVT1 expression levels in OC tissues. Kaplan-Meier survival analysis and log-rank test were used to evaluate the correlation between PVT1 expression levels and overall survival rate of OC patients. *P < 0.05, **P < 0.01.Mechanistically, miR-133a was identified to serve as a direct downstream target of PVT1 in OC. Knockdown of PVT1 inhibited cell proliferation, migration and invasion through negative regulating miR-133a in OC cells.The long non-coding RNA, plasmacytoma variant translocation 1 (PVT1), was reportedly to be highly expressed in a variety of tumors including ovarian cancer (OC). |
| Pubmed ID | 29957467 |
| Year | 2018 |
| Title | Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. |
| External Links |
| Links for PVT1 | GenBank HGNC lncrnadb Noncode |
| Links for ovarian cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.